Evidence map›Paper›PMID 27991900›Full record

ArticleNature neuroscience2017

Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes.

Roman A Romanov, Amit Zeisel, Joanne Bakker, Fatima Girach, Arash Hellysaz, Raju Tomer, Alán Alpár, Jan Mulder, Frédéric Clotman, Erik Keimpema and 21 more

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 265 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
265citing papers in PubMed, 1 pooled it
22.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

265 citing papers in PubMed, 1 synthesis or guideline pooled it, 525 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

205 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 13 institutions in 8 countries.

Roman A RomanovDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Amit ZeiselDivision of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Joanne BakkerDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Fatima GirachDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Arash HellysazDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Raju TomerDepartment of Bioengineering &CNC Program, Stanford University, Stanford, California, USA.
Alán AlpárMTA-SE NAP Research Group of Experimental Neuroanatomy and Developmental Biology, Hungarian Academy of Sciences, Budapest, Hungary.
Jan MulderScience for Life Laboratories, Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Frédéric ClotmanLaboratory of Neural Differentiation, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium.
Erik KeimpemaDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Brian HsuehDepartment of Bioengineering &CNC Program, Stanford University, Stanford, California, USA.
Ailey K CrowDepartment of Bioengineering &CNC Program, Stanford University, Stanford, California, USA.
Henrik MartensSynaptic Systems GmbH, Göttingen, Germany.
Christian SchwindlingMicroscopy Labs Munich, Global Sales Support-Life Sciences, Carl Zeiss Microscopy GmbH, Munich, Germany.
Daniela CalvigioniDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Jaideep S BainsThe Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Zoltán MátéInstitute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
Gábor SzabóInstitute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
Yuchio YanagawaDepartment of Genetic and Behavioral Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Japan.
Ming-Dong ZhangDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Andre RendeiroCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0001-9362-5373
Matthias FarlikCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Mathias UhlénScience for Life Laboratory, Albanova University Center, Royal Institute of Technology, Stockholm, Sweden.
Peer WulffInstitute of Physiology, Christian Albrechts University, Kiel, Germany.
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0001-6091-3088
Christian BrobergerDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Karl DeisserothDepartment of Bioengineering &CNC Program, Stanford University, Stanford, California, USA.
Tomas HökfeltDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Sten LinnarssonDivision of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Tamas L HorvathProgram in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Tibor HarkanyDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Karolinska Institutet · SEStanford University · USAustrian Academy of Sciences · ATMedical University of Vienna · ATHUN-REN Institute of Experimental Medicine · HUScience for Life Laboratory · SECarl Zeiss (Germany) · DEChristian-Albrechts-Universität zu Kiel · DEGunma University · JPSemmelweis University · HUUCLouvain · BEUniversity of Calgary · CAYale University · US

Funding

The role of AgRP/Auga-ALK pathway in FGF21's brain action on agingP01AG051459 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2016 to 2026
$25.7M
European Research Council 695136NIA NIH HHS P01 AG051459
6 · The paper itself

Abstract

The hypothalamus contains the highest diversity of neurons in the brain. Many of these neurons can co-release neurotransmitters and neuropeptides in a use-dependent manner. Investigators have hitherto relied on candidate protein-based tools to correlate behavioral, endocrine and gender traits with hypothalamic neuron identity. Here we map neuronal identities in the hypothalamus by single-cell RNA sequencing. We distinguished 62 neuronal subtypes producing glutamatergic, dopaminergic or GABAergic markers for synaptic neurotransmission and harboring the ability to engage in task-dependent neurotransmitter switching. We identified dopamine neurons that uniquely coexpress the Onecut3 and Nmur2 genes, and placed these in the periventricular nucleus with many synaptic afferents arising from neuromedin S

Indexed as

AnimalsDopamineDopaminergic NeuronsHypothalamusImmunohistochemistryMice, Inbred C57BLMice, TransgenicNeuropeptidesNeurotransmitter AgentsSuprachiasmatic NucleusSynaptic TransmissionTyrosine 3-MonooxygenaseDopamineneuromedin SNeuropeptidesNeurotransmitter AgentsTyrosine 3-Monooxygenase

Identifiers

PMID27991900
PMCPMC7615022
OpenAlexW2562003322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.